Fides Clinical Research is a clinical research site located in Atlanta, Georgia, United States 30342.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Fides Clinical Research has participated in 7 clinical trials with 5 currently active.
Therapeutic areas: Proteinuric Kidney Disease, Diabetic Nephropathies, Primary Focal Segmental Glomerulosclerosis.
Sponsors: Vertex Pharmaceuticals Incorporated, Walden Biosciences, Eli Lilly and Company.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Fides Clinical Research has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Fides Clinical Research has 7 clinical trials on record, with 5 currently active. Their work covers Proteinuric Kidney Disease, Diabetic Nephropathies, Primary Focal Segmental Glomerulosclerosis.
Yes — Fides Clinical Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.